HCA Healthcare, Inc. (NYSE:HCA) Stock Has Consensus Target Price of $480.13 According to Analysts
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Analysts have assigned HCA Healthcare (NYSE:HCA) an average "Moderate Buy" rating, with a consensus 12-month price target of $480.13. The company recently surpassed earnings and revenue expectations, reporting $7.22 EPS against a $6.65 consensus and Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context